MAPT and early-onset autosomal dominant Alzheimer disease: By regulating GSK-3β and Tau protein, the PI3K/Akt signaling pathway affects a variety of CNS diseases, such as Alzheimer’s disease, Parkinson’s disease, and Huntington’s disease (Kitagishi et al., 2014; Rai et al., 2019).